© Columbia University Press
The Risks of Prescription Drugs
Paper, 184 pages,
ISBN: 978-0-231-14693-7
$15.00
/ £10.50
October, 2010
Cloth, 184 pages,
ISBN: 978-0-231-14692-0
$45.00
/ £31.00
"The Risks of Prescription Drugs explains in clear, concise, and unflinching language the consequences of ignoring the discrepancy between the drug industry's private interests and the public service we hope and naïvely expect from them. This book provides consumers with tools for self-defense and concerned citizens with a road map for rebalancing American medicine." — John Abramson, Harvard Medical School, author of Overdosed America: The Broken Promise of American Medicine
"This volume introduces important debates on pharmaceutical promotion and marketing, needed drug evaluation and regulation, professional conflicts of interest, and increased medicalization of behavior. It explores important trends and policy questions that all engaged citizens should consider." — David Mechanic, Rutgers Institute for Health, Health Care Policy, and Aging Research, and author of The Truth About Health Care: Why Reform Is Not Working in America
"Although many are aware that pharmaceutical industry lobbyists influence policy decisions, few know the full consequences. In this enlightening book, some of the nation's leading health policy experts expose the risks to Americans posed by the pharmaceutical industry." — Jill Quadagno, former president of the American Sociological Association, author of The Transformation of Old Age Security